Bilateral cochlear implantation in bilateral Langerhans cell histiocytosis

Jamie M. Segel, Brian McKinnon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Langerhans' cell histiocytosis (LCH) is a rare proliferative disorder that can have otologic manifestations in up to 30% of patients. Treatment of local and systemic disease may include medical, surgical, and radiation therapies. Involvement of the temporal bone can lead to conductive and, rarely, sensorineural hearing loss. Post-labyrinthectomy cochlear implantation can be an effective treatment option for sensorineural hearing loss in the setting of persistent LCH. Methods: A retrospective case review at a tertiary academic medical center. Hearing in Noise Test (HINT) performed before and after bilateral cochlear implantation was examined. Results: Following bilateral partial labyrinthectomy, post-operative testing showed a HINT in quiet of 17%. Left-sided cochlear implant followed by immunosuppressive therapy for persistent disease showed marked improvement with post-operative HINT in a quiet room of 80% and 63% at 1 and 2 years. Fifty-five months after left implantation, and 10 months after right cochlear implantation, binaural post-operative HINT in quiet was 81%. Conclusion: Surgical excision of LCH lesion remains a mainstay of treatment for temporal bone involvement. Bilateral cochlear implant with adjuvant immunosuppression in our patient demonstrated both immediate and delayed improvement in auditory function after staged cochlear implantation in the setting of persistent disease.

Original languageEnglish (US)
Pages (from-to)178-180
Number of pages3
JournalCochlear Implants International
Volume14
Issue number3
DOIs
StatePublished - Jun 21 2013
Externally publishedYes

Fingerprint

Cochlear Implantation
Langerhans Cell Histiocytosis
Hearing
Noise
Cochlear Implants
Sensorineural Hearing Loss
Temporal Bone
Therapeutics
Immunosuppressive Agents
Immunosuppression
Radiotherapy

Keywords

  • Cochlear implant
  • Langerhans' histiocytosis

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Speech and Hearing
  • Medicine(all)

Cite this

Bilateral cochlear implantation in bilateral Langerhans cell histiocytosis. / Segel, Jamie M.; McKinnon, Brian.

In: Cochlear Implants International, Vol. 14, No. 3, 21.06.2013, p. 178-180.

Research output: Contribution to journalArticle

@article{13dbd4f46ab44cd3b916bad8c89a1180,
title = "Bilateral cochlear implantation in bilateral Langerhans cell histiocytosis",
abstract = "Background: Langerhans' cell histiocytosis (LCH) is a rare proliferative disorder that can have otologic manifestations in up to 30{\%} of patients. Treatment of local and systemic disease may include medical, surgical, and radiation therapies. Involvement of the temporal bone can lead to conductive and, rarely, sensorineural hearing loss. Post-labyrinthectomy cochlear implantation can be an effective treatment option for sensorineural hearing loss in the setting of persistent LCH. Methods: A retrospective case review at a tertiary academic medical center. Hearing in Noise Test (HINT) performed before and after bilateral cochlear implantation was examined. Results: Following bilateral partial labyrinthectomy, post-operative testing showed a HINT in quiet of 17{\%}. Left-sided cochlear implant followed by immunosuppressive therapy for persistent disease showed marked improvement with post-operative HINT in a quiet room of 80{\%} and 63{\%} at 1 and 2 years. Fifty-five months after left implantation, and 10 months after right cochlear implantation, binaural post-operative HINT in quiet was 81{\%}. Conclusion: Surgical excision of LCH lesion remains a mainstay of treatment for temporal bone involvement. Bilateral cochlear implant with adjuvant immunosuppression in our patient demonstrated both immediate and delayed improvement in auditory function after staged cochlear implantation in the setting of persistent disease.",
keywords = "Cochlear implant, Langerhans' histiocytosis",
author = "Segel, {Jamie M.} and Brian McKinnon",
year = "2013",
month = "6",
day = "21",
doi = "10.1179/1754762812Y.0000000023",
language = "English (US)",
volume = "14",
pages = "178--180",
journal = "Cochlear Implants International",
issn = "1467-0100",
publisher = "Maney Publishing",
number = "3",

}

TY - JOUR

T1 - Bilateral cochlear implantation in bilateral Langerhans cell histiocytosis

AU - Segel, Jamie M.

AU - McKinnon, Brian

PY - 2013/6/21

Y1 - 2013/6/21

N2 - Background: Langerhans' cell histiocytosis (LCH) is a rare proliferative disorder that can have otologic manifestations in up to 30% of patients. Treatment of local and systemic disease may include medical, surgical, and radiation therapies. Involvement of the temporal bone can lead to conductive and, rarely, sensorineural hearing loss. Post-labyrinthectomy cochlear implantation can be an effective treatment option for sensorineural hearing loss in the setting of persistent LCH. Methods: A retrospective case review at a tertiary academic medical center. Hearing in Noise Test (HINT) performed before and after bilateral cochlear implantation was examined. Results: Following bilateral partial labyrinthectomy, post-operative testing showed a HINT in quiet of 17%. Left-sided cochlear implant followed by immunosuppressive therapy for persistent disease showed marked improvement with post-operative HINT in a quiet room of 80% and 63% at 1 and 2 years. Fifty-five months after left implantation, and 10 months after right cochlear implantation, binaural post-operative HINT in quiet was 81%. Conclusion: Surgical excision of LCH lesion remains a mainstay of treatment for temporal bone involvement. Bilateral cochlear implant with adjuvant immunosuppression in our patient demonstrated both immediate and delayed improvement in auditory function after staged cochlear implantation in the setting of persistent disease.

AB - Background: Langerhans' cell histiocytosis (LCH) is a rare proliferative disorder that can have otologic manifestations in up to 30% of patients. Treatment of local and systemic disease may include medical, surgical, and radiation therapies. Involvement of the temporal bone can lead to conductive and, rarely, sensorineural hearing loss. Post-labyrinthectomy cochlear implantation can be an effective treatment option for sensorineural hearing loss in the setting of persistent LCH. Methods: A retrospective case review at a tertiary academic medical center. Hearing in Noise Test (HINT) performed before and after bilateral cochlear implantation was examined. Results: Following bilateral partial labyrinthectomy, post-operative testing showed a HINT in quiet of 17%. Left-sided cochlear implant followed by immunosuppressive therapy for persistent disease showed marked improvement with post-operative HINT in a quiet room of 80% and 63% at 1 and 2 years. Fifty-five months after left implantation, and 10 months after right cochlear implantation, binaural post-operative HINT in quiet was 81%. Conclusion: Surgical excision of LCH lesion remains a mainstay of treatment for temporal bone involvement. Bilateral cochlear implant with adjuvant immunosuppression in our patient demonstrated both immediate and delayed improvement in auditory function after staged cochlear implantation in the setting of persistent disease.

KW - Cochlear implant

KW - Langerhans' histiocytosis

UR - http://www.scopus.com/inward/record.url?scp=84879060740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879060740&partnerID=8YFLogxK

U2 - 10.1179/1754762812Y.0000000023

DO - 10.1179/1754762812Y.0000000023

M3 - Article

C2 - 23433528

AN - SCOPUS:84879060740

VL - 14

SP - 178

EP - 180

JO - Cochlear Implants International

JF - Cochlear Implants International

SN - 1467-0100

IS - 3

ER -